Cargando…

ME1 promotes basal-like breast cancer progression and associates with poor prognosis

Basal-like breast cancer (BLBC) is associated with a poor clinical outcome due to the few treatment options and absence of effective targeted agents. Here, we show that malic enzyme 1 (ME1) is dramatically upregulated in BLBC due to ME1 copy number amplification. ME1 expression increases glucose upt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Ruocen, Ren, Guoping, Liu, Huixin, Chen, Xingyu, Cao, Qianhua, Wu, Xuebiao, Li, Jun, Dong, Chenfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233160/ https://www.ncbi.nlm.nih.gov/pubmed/30425310 http://dx.doi.org/10.1038/s41598-018-35106-y

Ejemplares similares

Loss of ABAT-Mediated GABAergic System Promotes Basal-Like Breast Cancer Progression by Activating Ca(2+)-NFAT1 Axis
por: Chen, Xingyu, et al.
Publicado: (2019)

Inhibition of UGT8 suppresses basal-like breast cancer progression by attenuating sulfatide–αVβ5 axis
por: Cao, Qianhua, et al.
Publicado: (2018)

AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program
por: Wu, Xuebiao, et al.
Publicado: (2017)

Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer
por: Huang, Panpan, et al.
Publicado: (2020)

HIST1H1B Promotes Basal-Like Breast Cancer Progression by Modulating CSF2 Expression
por: Liao, Ruocen, et al.
Publicado: (2021)

Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness
por: Miao, Zhaorui, et al.
Publicado: (2022)

Twist-mediated PAR1 induction is required for breast cancer progression and metastasis by inhibiting Hippo pathway
por: Wang, Yifan, et al.
Publicado: (2020)

NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis
por: Jiang, Feng, et al.
Publicado: (2022)

Stromal Infiltration of Tumor-Associated Macrophages Conferring Poor Prognosis of Patients with Basal-Like Breast Carcinoma
por: Yang, Mu, et al.
Publicado: (2018)

Bromodomain PHD-finger transcription factor promotes glioma progression and indicates poor prognosis
por: Pan, Yanling, et al.
Publicado: (2019)

LSD1 Overexpression Is Associated with Poor Prognosis in Basal-Like Breast Cancer, and Sensitivity to PARP Inhibition
por: Nagasawa, Satoi, et al.
Publicado: (2015)

The suppression of DUSP5 expression correlates with paclitaxel resistance and poor prognosis in basal-like breast cancer
por: Liu, Tieju, et al.
Publicado: (2018)

MFAP5 promotes basal-like breast cancer progression by activating the EMT program
por: Wu, Yanmei, et al.
Publicado: (2019)

GABRD promotes progression and predicts poor prognosis in colorectal cancer
por: Niu, Gengming, et al.
Publicado: (2020)

Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers
por: Yan, Max, et al.
Publicado: (2011)

Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation
por: Kormelink, Tom Groot, et al.
Publicado: (2014)

Increased α-actinin-1 destabilizes E-cadherin-based adhesions and associates with poor prognosis in basal-like breast cancer
por: Kovac, Bianca, et al.
Publicado: (2018)

MIR31HG Expression Predicts Poor Prognosis and Promotes Colorectal Cancer Progression
por: Wang, Jianlong, et al.
Publicado: (2022)

The Upregulation of GSTO2 is Associated with Colon Cancer Progression and a Poor Prognosis
por: Peng, Xingyu, et al.
Publicado: (2023)

Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling
por: Bhardwaj, Anjana, et al.
Publicado: (2015)

Identification and evaluation of network modules for the prognosis of basal-like breast cancer
por: Hallett, Robin M., et al.
Publicado: (2015)

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

KCNH3 Predicts Poor Prognosis and Promotes Progression in Ovarian Cancer
por: Li, Zhongjun, et al.
Publicado: (2020)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

FOXD1 is associated with poor outcome and maintains tumor-promoting enhancer–gene programs in basal-like breast cancer
por: Kumegawa, Kohei, et al.
Publicado: (2023)

Keratin19 promotes pancreatic cancer progression and poor prognosis via activating the Hedgehog pathway
por: Zhou, Changsheng, et al.
Publicado: (2023)

Stem Cell Determinant SOX9 Promotes Lineage Plasticity and Progression in Basal-like Breast Cancer
por: Christin, John R., et al.
Publicado: (2020)

Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation
por: Erdélyi, Katalin, et al.
Publicado: (2021)

Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis
por: Dai, Da-nian, et al.
Publicado: (2017)

Overexpression of Raf-1 in basal-like carcinoma of the breast: correlation with clinicopathology and prognosis
por: Wu, Ping, et al.
Publicado: (2014)

CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer
por: Zhang, Xiao‐Guang, et al.
Publicado: (2018)

Downregulation of microRNA-605 indicates poor prognosis and promotes the progression of osteosarcoma
por: Yi, Xiuling, et al.
Publicado: (2020)

SERPINE1 Overexpression Promotes Malignant Progression and Poor Prognosis of Gastric Cancer
por: Chen, Shujia, et al.
Publicado: (2022)

DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis
por: Xia, Leilei, et al.
Publicado: (2021)

RNF20 Is Critical for Snail-Mediated E-Cadherin Repression in Human Breast Cancer
por: Wang, Danping, et al.
Publicado: (2020)

Upregulation of SNTB1 correlates with poor prognosis and promotes cell growth by negative regulating PKN2 in colorectal cancer
por: Liu, Liya, et al.
Publicado: (2021)

FERMT1 promotes gastric cancer progression by activating the NF-κB pathway and predicts poor prognosis
por: Fan, Hua, et al.
Publicado: (2020)

Grainyhead-like 2 Promotes Tumor Growth and is Associated with Poor Prognosis in Colorectal Cancer
por: Quan, Yingjun, et al.
Publicado: (2015)

Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer
por: Ni, Jun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d96ujpnjrthoquh8aj37hjdkfm